Amniocentesis Needle Market Size & Share 2026-2035

Amniocentesis Needle Market Size

The global amniocentesis needle market size was valued at USD 194.2 million in 2025. The market is expected to grow from USD 203.7 million in 2026 to USD 316.9 million in 2035, growing at a CAGR of 5%, according to the latest report published by Global Market Insights Inc.

The steady growth of the market is driven by increasing maternal age and high-risk pregnancies, the growing burden of congenital disorders, the rising prevalence of chronic diseases among expectant mothers, and technological advancements in amniocentesis needles. The global market increased from USD 168.6 million in 2022 to USD 185.2 million in 2024. The growing burden of congenital disorders is a significant factor driving market growth. For instance, according to WHO, an estimated 240,000 newborns die within 28 days of birth each year due to congenital disorders, with an additional 170,000 deaths occurring between 1 month and 5 years of age.
 

Congenital disorders are also a leading cause of long-term disabilities, imposing a significant burden on the healthcare systems of various countries. Notably, nine out of ten children born with serious congenital disorders are in low- and middle-income countries. These statistics underscore the critical role of amniocentesis needles in enabling early and accurate prenatal diagnosis, which is essential for timely intervention and improved maternal-fetal outcomes. 

Additionally, increasing maternal age and the rising prevalence of high-risk pregnancies are major factors driving the demand for amniocentesis needles. Advanced maternal age is strongly associated with chromosomal abnormalities such as Down syndrome, making invasive diagnostic procedures such as amniocentesis essential for accurate prenatal screening. According to a study published by the NIH, the prevalence of high-risk pregnancies among Indian women was 49.4%, with 33% having a single high-risk factor and 16.4% having multiple high-risk factors. This growing trend underscores the critical need for reliable diagnostic tools, positioning amniocentesis needles as a vital component in managing maternal-fetal health and reducing complications through early detection.

An amniocentesis needle is a specialized medical instrument used during the amniocentesis procedure, which involves extracting a small amount of amniotic fluid from the amniotic sac surrounding a developing fetus. This fluid is analyzed for genetic, chromosomal, and biochemical abnormalities, helping in the early detection of conditions such as Down syndrome, neural tube defects, and other congenital disorders.
 

Amniocentesis Needle Market Trends

• Technological innovations in amniocentesis needles have significantly improved the safety, accuracy, and efficiency of prenatal diagnostic procedures. Modern designs aim to reduce procedural risks such as infections, while enhancing patient comfort and clinician control. These advancements are essential in addressing the growing demand for precise prenatal testing, particularly in high-risk pregnancies.
   
• The development of echogenic-tipped needles is offering enhanced visibility under ultrasound guidance and enabling clinicians to position the needle accurately and reduce complications. Steerable needles, represent another significant advancement, allowing controlled directional adjustments during insertion to improve targeting and minimize risks to maternal and fetal tissues.
   
• For example, Cook Medical’s EchoTip disposable amniocentesis needles are designed to enhance procedural safety and accuracy. They feature an echogenic tip for superior ultrasound visibility, centimeter depth markings for precise insertion, and a single-use sterile design to reduce infection risk.
   
• Additionally, ultra-thin and flexible needles have been introduced to minimize trauma to maternal and fetal tissues. Safety-engineered needles with protective sheaths and single-use sterile designs further reduce infection risks and cross-contamination.
   
• Further, these technological advancements have significantly improved clinical outcomes by reducing procedural errors and enhancing diagnostic accuracy. They also streamline workflow efficiency in hospitals and diagnostic centres, enabling practitioners to perform procedures with greater confidence and speed.
   

Amniocentesis Needle Market Analysis

Based on product type, the global amniocentesis needle market is segmented into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The 100 to 150 mm segment dominated the market with the largest revenue share of 52.2% in 2025.
 

• Amniocentesis needles ranging from 100 mm to 150 mm are designed for mid- to late-gestation procedures, where the increased distance between the skin surface and the amniotic sac requires longer needle reach. These longer shafts ensure safe fluid access in larger or more advanced pregnancies, accommodating variations in patient anatomy.
   
• Advanced amniocentesis needles also incorporate features such as side-port designs to improve fluid aspiration efficiency, even if the main lumen becomes partially obstructed. Some models use spiral engraving near the tip to enhance ultrasound reflectivity, ensuring precise needle placement in challenging anatomical conditions.
   
• Additionally, color-coded hubs simplify gauge identification, while self-locating stylets maintain lumen patency during insertion. These design improvements collectively enhance procedural safety, reduce complications, and improve clinician confidence during prenatal diagnostics.
   
• For example, CooperSurgical’s Wallace amniocentesis needle (150 mm, 21 G) combines advanced features such as a spiral-engraved echogenic tip for superior ultrasound visibility, a sharp non-coring design to minimize tissue trauma, and a self-locating stylet to maintain lumen patency. Its color-coded hub ensures easy identification, enhancing procedural efficiency and safety, thus driving market growth.
   

Based on procedure, the amniocentesis needle market is segmented into amniocentesis procedures, amnioreduction procedures, fetal blood transfusions, amnioinfusion procedures, and cordocentesis procedures. The amniocentesis procedures segment dominated the market, with a share of 33.2% in 2025.
 

• Amniocentesis is a minimally invasive prenatal diagnostic procedure typically performed between 15–20 weeks of gestation, using continuous ultrasound guidance to ensure safety and accuracy.
   
• It plays a crucial role in detecting genetic abnormalities such as Down syndrome, trisomy 18, and neural tube defects, while also enabling detailed chromosomal analysis of the fetus. Its reliability is well established, with the National Health Service reporting a definitive accuracy rate of approximately 98–99%, making it one of the most trusted methods for genetic screening and driving its widespread clinical adoption.
   
• Furthermore, advanced needle designs are incorporating features such as sharp, non-coring tips which minimize tissue trauma, and echogenic markings or spiral engravings that enhance ultrasound visibility ensuring precise placement even in complex anatomical conditions. These factors collectively improve outcomes and contribute to market growth.
   

Based on end use, the amniocentesis needle market is segmented into hospitals, diagnostic centres, clinics, and other end users. The hospitals segment dominated the market with the largest revenue of USD 99 million in 2025.
 

• Hospitals are the primary settings for amniocentesis due to their multidisciplinary maternal-fetal medicine units, access to high-resolution ultrasound, and established sterile procedure protocols. Most amniocentesis procedures are conducted in hospital-based clinics or day-care units under continuous ultrasound guidance. This process requires reliable, purpose-built needles and standardized kits to ensure safe and reproducible access to the amniotic sac.
   
• Innovative products with features such as echogenic tips, color-coded hubs, and sterile single-use packaging are offering enhancement to the hospital workflows by improving ultrasound visibility, reducing needle passes, and increasing safety. These advancements align with quality goals and support the broader adoption of amniocentesis.
   
• Additionally, hospital demand for advanced amniocentesis needles is driven by the high volume of high-risk pregnancies and referrals for definitive genetic testing. There is a preference for needles with echogenic markings, non-coring tips, and stylets to ensure safety and standardize performance across operators.
   

North America Amniocentesis Needle Market

North America dominated the market with a share of 38.2% in 2025. The U.S. market is projected to grow significantly, from USD 68.3 million in 2025 to USD 106.9 million by 2035. USD 106.9 million by 2035.
 

• The increasing prevalence of congenital disorders is the key driver for the growth of the market in the U.S.
   
• For instance, according to CDC data in 2023, congenital anomalies occur in approximately 1 in every 33 infants born in the U.S. each year. This significant incidence underscores the need for reliable diagnostic tools such as amniocentesis, which offers definitive results for chromosomal and genetic analysis.
   
• Furthermore, the rising burden of congenital disorders is prompting hospitals and healthcare providers to adopt advanced amniocentesis techniques and devices. These include needles with echogenic tips, non-coring designs, and color-coded hubs that improve safety, accuracy, and procedural efficiency.
   

Europe Amniocentesis Needle Market

Europe market accounted for USD 53.2 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• The rising maternal age and increasing incidence of high-risk pregnancies across Europe are key factors driving demand for amniocentesis procedures and advanced needle designs. Government initiatives promoting prenatal screening and diagnostic programs further strengthen adoption, as hospitals seek reliable tools for accurate genetic testing.
   
• Additionally, the strong presence of leading medical device manufacturers in Europe reinforces the region’s market position. These companies are actively innovating needle technology such as echogenic tips, non-coring designs, and ergonomic hubs to improve safety and efficiency, thereby accelerating market growth.
   

The amniocentesis needle market in Germany is expected to experience significant and promising growth from 2026 to 2035.

• Germany is emerging as a key market for advanced amniocentesis needles, supported by its strong healthcare infrastructure, specialized maternal-fetal medicine centers, and growing adoption of precision prenatal diagnostics. Hospitals and clinics increasingly rely on ultrasound-guided procedures, driving demand for high-quality, echogenic, and non-coring needle designs.
   
• Government-backed initiatives and investments in hospital modernization, coupled with Germany’s leadership in medical technology innovation, further accelerate the integration of advanced amniocentesis solutions. Features such as spiral-engraved tips for enhanced ultrasound visibility, color-coded hubs, and sterile single-use packaging align with clinical safety standards, improving diagnostic accuracy and patient outcomes.
   

Asia Pacific Amniocentesis Needle Market

The Asia Pacific market is projected to grow at the CAGR of 5.6% during the analysis timeframe.
 

• The Asia Pacific market is experiencing rapid growth due to the increasing prevalence of genetic disorders, rising awareness about prenatal testing, and continuous advancements in obstetric care and diagnostic technologies.
   
• Improvements in healthcare infrastructure, including the establishment of new maternity hospitals and diagnostic centres, along with the geographical expansion of medical device manufacturers, are driving the demand for advanced amniocentesis needles. These developments ensure safe and accurate prenatal procedures, thereby fuelling market growth in the region.
   
• Additionally, supportive government initiatives and policies aimed at enhancing maternal and fetal health, coupled with growing investments in research and development for prenatal diagnostics, are further contributing to the expansion of the market in the Asia Pacific.
   

China amniocentesis needle market is anticipated to witness lucrative growth between 2026 - 2035.

• Government initiatives and regulatory frameworks play a crucial role in shaping the market. The National Health Commission of China has introduced stringent quality standards for antenatal screening and diagnostic procedures, ensuring safety and accuracy in prenatal testing. These regulations are expected to drive demand for standardized, high-quality amniocentesis needles as compliance becomes a priority for healthcare providers.
   
• Several factors are fuelling the demand for amniocentesis needles in China. The country has witnessed a surge in prenatal diagnostic rates, supported by improved healthcare infrastructure and the availability of advanced obstetric care.
   
• Additionally, the growing adoption of minimally invasive procedures in hospitals and diagnostic centres has increased the need for high-quality, precision needles. The expansion of medical device manufacturers and distributors across urban and semi-urban areas further supports market penetration.
   

Latin America Amniocentesis Needle Market

The Brazil market is expected to experience significant and promising growth from 2026 to 2035.

• Brazil's commitment to improving maternal and fetal healthcare, supported by public and private investments, has resulted in the establishment of advanced maternity hospitals and diagnostic centres. These facilities require high-quality and precise amniocentesis needles for safe prenatal testing.
   
• The rising adoption of prenatal screening and diagnostic procedures, along with an increasing focus on personalized obstetric care, significantly boosts the demand for technologically advanced amniocentesis needle solutions in Brazil.
   

Middle East and Africa Amniocentesis Needle Market

The Saudi Arabia market is expected to experience significant and promising growth from 2026 to 2035.

• Saudi Arabia's Vision 2030 initiative emphasizes the development of advanced healthcare systems and the expansion of maternal and fetal health services. This creates strong demand for high-quality and precise amniocentesis needles for safe prenatal diagnostic procedures.
   
• Moreover, increased government and private sector funding for healthcare infrastructure, combined with the establishment of modern maternity hospitals and diagnostic centres, further accelerates the adoption of advanced amniocentesis needle solutions in the country.
   

Amniocentesis Needle Market Share

• The top five players in the market, including Becton, Dickinson and Company, The Cooper Companies, Medline Industries, Cardinal Health and McKesson Corporation, collectively held 35% of the global market in 2025. These companies have continued to strengthen their positions through product innovation, adherence to stringent regulatory standards, and strategic partnerships. Leading players are investing heavily in research and development to introduce next-generation amniocentesis needles with enhanced safety features, precision engineering, and compatibility with advanced imaging systems.
   
• Becton, Dickinson and Company maintains a strong position in the amniocentesis needle segment by offering high-quality, precision-engineered needles designed for optimal patient safety and clinician ease of use. The company is focused on developing needles with improved echogenicity for better ultrasound visibility, ergonomic designs for enhanced handling, and advanced safety mechanisms to minimize procedural risks. BD is also investing in material innovations and sterile packaging solutions to ensure compliance with global healthcare standards and improve overall clinical outcomes.
   
• Manufacturers are adopting value-based pricing strategies to penetrate cost-sensitive markets, particularly in emerging economies. Leading players are addressing clinical needs by launching needles with integrated safety shields, improved gauge options, and compatibility with minimally invasive techniques, ensuring reliability and convenience for both hospital and outpatient settings. These advancements aim to reduce complications, improve diagnostic accuracy, and enhance accessibility, supporting better management of prenatal diagnostic procedures.
   
• Emerging trends in the market include the integration of ultrasound-guided needle designs for improved precision, as well as the development of eco-friendly materials and sustainable manufacturing practices to reduce environmental impact. There is also a growing focus on single-use sterile products to minimize infection risks and innovative packaging solutions for safe disposal, aligning with global healthcare sustainability goals.
   

Amniocentesis Needle Market Companies

Some of the eminent market participants operating in the global amniocentesis needle industry include:

• Becton, Dickinson and Company
• Biopsybell
• Cardinal Health
• Eurosurgical
• Laboratoire
• M.D.L S.R.L.
• McKesson Corporation
• Medax S
• Medline Industries
• Moller Medical GmbH
• RI.MOS
• Roko AB
• Suzhou Leapmed Healthcare Corporation
• The Cooper Companies
• Vigeo srl
   

• Becton, Dickinson and Company
   

Becton, Dickinson and Company (BD) is a global leader in medical technology, offering precision-engineered amniocentesis needles with enhanced safety, ultrasound visibility, and ergonomic designs. BD prioritizes advanced safety mechanisms, sterile packaging, and material innovations to ensure compliance and improve patient outcomes.
 

• McKesson Corporation
   

McKesson Corporation is a prominent healthcare services and medical supply distributor, providing a comprehensive range of amniocentesis needles and related products to hospitals, clinics, and diagnostic centers. McKesson emphasizes supply chain efficiency, cost-effective solutions, and adherence to global healthcare standards.
 

• Cardinal Health
   

Cardinal Health is a key player in the medical device distribution space, offering amniocentesis needles and accessories for obstetric and gynecological procedures. The company focuses on ensuring product availability, affordability, and compliance with international safety standards.
 

Amniocentesis Needle Industry News:
 

• In May 2023, Cardinal Health announced plans to establish a new distribution center in the Greater Toronto Area (GTA), expanding its network to nine strategic locations. This move aims to improve supply chain efficiency and address the growing demand for medical and surgical products, including accessories and needles, across the Canadian healthcare system, thereby driving the company’s sales growth.
   

The global amniocentesis needle market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• 100 to 150 mm                  
• Smaller than 100 mm                   
• Larger than 150 mm
   

Market, By Procedure

• Amniocentesis procedures             
• Amnioreduction procedures           
• Fetal blood transfusion                  
• Amnioinfusion procedures             
• Cordocentesis procedures           
               

Market, By End Use

• Hospitals                                                          
• Diagnostics centers                                                     
• Clinics                                                    
• Other end users        
                                          

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE